1. Home
  2. SDOT vs PRFX Comparison

SDOT vs PRFX Comparison

Compare SDOT & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sadot Group Inc.

SDOT

Sadot Group Inc.

HOLD

Current Price

$23.45

Market Cap

3.2M

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$1.37

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDOT
PRFX
Founded
2014
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.6M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
SDOT
PRFX
Price
$23.45
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0M
3.2M
Earning Date
04-29-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
490.91
N/A
EPS
N/A
N/A
Revenue
$7,929,137.00
N/A
Revenue This Year
$12.76
N/A
Revenue Next Year
$5.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
60.08
N/A
52 Week Low
$0.14
$0.58
52 Week High
$106.00
$5.39

Technical Indicators

Market Signals
Indicator
SDOT
PRFX
Relative Strength Index (RSI) 49.85 45.16
Support Level $2.41 $1.27
Resistance Level $39.86 $1.59
Average True Range (ATR) 19.74 0.17
MACD -1.06 -0.01
Stochastic Oscillator 18.46 11.90

Price Performance

Historical Comparison
SDOT
PRFX

About SDOT Sadot Group Inc.

Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: